The Pneumonia Vaccine Market is expected to reach US$ 13.84 billion by 2031 at a CAGR of 5.20%.
FutureWise Research published a report that analyzes Pneumonia Vaccine Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in...
The Conjugate Vaccine Market consists of vaccines that contain bacterial capsular polysaccharides, or parts of bacteria, chemically bonded or conjugated to a carrier protein. Conjugate vaccines help develop stronger and longer-lasting immunity than plain polysaccharide vaccines, which do not contain a protein carrier. Conjugate vaccines target diseases such as bacterial meningitis, pneumonia...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian